* BIOQUANTA *
2003 - IDF
Paris
www.bioquanta.com Contract, Research
(also, Discovery, Drugs)
Key words: Clinical biology, Biochemistry, Molecular modeling, In-silico Toxicity Prediction, In-vitro metabolic Exploration, Diagnostic kit and drug development
Mission: to promote predictive and personalized medicine
Clients: Biotech companies, Pharmaceutical, Food and Cosmetics industries
contact@bioquanta.net
Age: 10 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS |
|---|
| Personal venture |
Managing Dir.-CEO: Rabeuf (Rémi) [M.Sc. biology, MBA, ex-Roche (20 years)]
Sc.Dir.-CSO:
Oper.Dir.-COO:
Fin.Dir.-CFO:
BusDev: Guidon (Romain) [MBA]
Financers (Hist.): privately-owned (undisclosed private investors) | Turnover (M€) : 0.53 (2010), 0.47 (2009), 0.31 (2008), 0.19 (2007)
Total funding (M€) : 0.5
Last funding (M€) : 0.5
Focus : Cancers
Position : Patents
Company confirm : 18-May-2011 |
History | DATE | MILESTONE | TYPE | TIME |
|---|
| 2010 .02 | Round-financing : 0.5 M€ (US$ 800 000) from private investors | RFIN | [7 years] |
| 2006 .03 | Set-up of BioQuanta Diagnostics | ORGC | [3 years] |
| 2003 .04 | Seed financing : undisclosed M€, by private investors | SFIN | [0 year] |
| 2003 .02 | Company founded by Jean-Michel Mauclaire and others, in Aurora (USA) as BioQuanta Inc. and set-up of subsidiary in France (SaRL) | ORGF | [0 year] | Actualisation / Updating: 18-May-2011 |
|
